Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effectiveness of Collaborative care and Duloxetine for major depressive disorder and (sub)chronic pain in primary care: a randomized placebo-controlled Multi-Centre trial.

Next Previous
Search
Trial Profile

Effectiveness of Collaborative care and Duloxetine for major depressive disorder and (sub)chronic pain in primary care: a randomized placebo-controlled Multi-Centre trial.

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Mar 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Major depressive disorder; Pain
  • Focus Therapeutic Use
  • Acronyms PAINDIP
  • Sponsors Eli Lilly and Company

Most Recent Events

  • 03 Feb 2014 Planned number of patients changed from 237 to 219 as reported by European Clinical Trials Database record.
  • 07 Jun 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top